Newsroom
Sorted by: Latest
-
Data Center Insulation Market Forecast 2025-2032: Demand Drivers, Business Opportunities and Growth Challenges - GenAI-based Mega Centers and the Modernization of Legacy Data Centers - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Data Center Insulation Market by Material (Mineral Wool, PU Foam, PE Foam, Polystyrene Foam, Flexible Elastomeric Foam), Insulation Type (Thermal & Acoustic), Application (Wall & Roof, Raised Floors, Pipes & Ducts) and Region - Global Forecast to 2032" has been added to ResearchAndMarkets.com's offering. The data center insulation market is anticipated to expand significantly, from USD 0.57 billion in 2025 to USD 1.61 billion by 2032, growing at a CAGR...
-
Accenture Partners With U.S. Department of Energy to Support Groundbreaking Genesis Mission Program
ARLINGTON, Va.--(BUSINESS WIRE)--Accenture Federal Services, a wholly owned subsidiary of Accenture (NYSE: ACN), announced today its agreement to explore partnerships with the U.S. Department of Energy (DOE) to support the Genesis Mission. This era-defining initiative is a national imperative that will accelerate American leadership in the global Artificial Intelligence (AI) race and fundamentally transform the nation's science and technology ecosystem. The Genesis Mission, led by the DOE, seek...
-
AM Best Assigns Credit Ratings to Prismic Life Reinsurance, Ltd. and Prismic Life Reinsurance International, Ltd.
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Financial Strength Rating (FSR) of A- (Excellent) and a Long-Term Issuer Credit Rating (Long-Term ICR) of “a-” (Excellent) to Prismic Life Reinsurance, Ltd. (Prismic Life Re). In addition, AM Best has assigned an FSR of A- (Excellent) and a Long-Term ICR of “a-” (Excellent) to Prismic Life Reinsurance International, Ltd. (PL Re International) (both domiciled in Bermuda). The outlook assigned to these Credit Ratings (ratings) is stable. The...
-
Riassunto: Croma-Pharma presenta un nuovo dispositivo medico per la preparazione autologa di PRP | PRF liquida
LEOBENDORF, Austria--(BUSINESS WIRE)--Croma-Pharma, azienda protagonista globale nel settore della medicina estetica minimamente invasiva, è lieta di annunciare il lancio del suo nuovo dispositivo medico utilizzato per la preparazione autologa di plasma ricco di piastrine (PRP) | fibrina ricca di piastrine liquida (Fluid-PRF).1 Questo lancio rappresenta il progresso continuo nella missione di Croma di fornire ai professionisti sanitari strumenti all'avanguardia per la loro attività. Con il suo...
-
December 2025 Meeting: Port Houston Greenlights Key Initiatives for Global Trade and Future Capacity
HOUSTON--(BUSINESS WIRE)--On Tuesday, December 9, the Port Commission of the Port of Houston Authority met for its final meeting of the year, approving key initiatives that strengthen trade relationships, modernize operations, and expand critical infrastructure to support continued growth at Port Houston’s public terminals. Chairman Ric Campo reflected on the success of the 4th Annual Community Resource Fair, which drew over 7,000 attendees and 90 vendors, doubling 2024’s participation. He also...
-
Securities Fraud Investigation Into Above Food Ingredients Inc. (ABVE) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Above Food Ingredients Inc. (“Above Food” or the “Company”) (NASDAQ: ABVE) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ABOVE FOOD INGREDIENTS INC. (ABVE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On December 2, 2025, Above Food disclosed that...
-
CoinFlip Celebrates Grand Opening of First Crypto Center in Mexico City, Creating a Dedicated Storefront to Buy and Sell Cryptocurrency
MEXICO CITY--(BUSINESS WIRE)--CoinFlip, a leading U.S. based global digital currency platform company, celebrated the grand opening for CoinFlip’s first-ever Crypto Center. The Crypto Center, the first of its kind in Mexico City, provides a physical storefront that bridges the gap between customers’ digital wallets and the real world. Staffed by CoinFlip specialists, customers can speak with trusted experts to create and customize their digital portfolio, bringing an interactive component to bu...
-
JW Marriott Las Vegas and Rampart Casino Announce Property-Wide Rebrand, Officially Becoming The Resort at Summerlin
LAS VEGAS--(BUSINESS WIRE)--JW Marriott Las Vegas and Rampart Casino today announced a property-wide rebrand, officially uniting the celebrated resort and casino under a new identity, The Resort at Summerlin. Effective January 1, 2026, the rebrand marks a significant milestone in the property’s ongoing $75 million, multi-year renovation and its evolution as a premier luxury destination in the heart of Summerlin. The extensive renovation reflects a renewed focus on mindful luxury, well-being, an...
-
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy
CASABLANCA, Morocco--(BUSINESS WIRE)--500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. Launched by the Ministry of Digital Transition a...
-
Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity - Complex Challenges and Unprecedented Opportunities are Emerging - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Rare Diseases Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The rare diseases treatment market is entering a pivotal phase marked by advanced therapeutic innovation, multi-stakeholder collaboration, and fundamental changes to research and development processes. As global demand for effective rare disease therapies continues to expand, industry leaders are navigating a landscape shaped by emerging technolog...